An FDA plan to allow drug companies to distribute reprints of journal articles dealing with off-label drug uses has run into fire from Sen. Charles Grassley (R-IA), Public Citizen and two university professors even as an industry coalition began efforts in April to have the FDA loosen its proposal.
Trending Articles
More Pages to Explore .....